This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Takeyama, K.-I.
Right arrow Articles by Kato, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Takeyama, K.-I.
Right arrow Articles by Kato, S.

 Previous Article  |  Next Article 

Molecular and Cellular Biology, February 1999, p. 1049-1055, Vol. 19, No. 2
0270-7306/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.

Selective Interaction of Vitamin D Receptor with Transcriptional Coactivators by a Vitamin D Analog

Ken-Ichi Takeyama,1 Yoshikazu Masuhiro,1 Hiroaki Fuse,1 Hideki Endoh,1 Akiko Murayama,1 Sachiko Kitanaka,1 Miyuki Suzawa,1 Junn Yanagisawa,1 and Shigeaki Kato1,2,*

Institute of Molecular and Cellular Biosciences, The University of Tokyo, Tokyo 113,1 and Core Research for Evolutional Science and Technology, Japan Science and Technology Corporation, Saitama 332,2 Japan

Received 20 July 1998/Returned for modification 8 September 1998/Accepted 6 November 1998

The nuclear vitamin D receptor (VDR) is a member of a nuclear receptor superfamily and acts as a ligand-dependent transcription factor. A family of cotranscriptional activators (SRC-1, TIF2, and AIB-1) interacts with and activates the transactivation function of nuclear receptors in a ligand-dependent way. We examined interaction of VDR with these coactivators that was induced by several vitamin D analogs, since they exert differential subsets of the biological action of vitamin D through unknown mechanisms. Unlike other vitamin D analogs tested, OCT (22-oxa-1alpha ,25-dihydroxyvitamin D3) induced interaction of VDR with TIF2 but not with SRC-1 or AIB-1. Consistent with these interactions, only TIF2 was able to potentiate the transactivation function of VDR bound to OCT. Thus, the present findings suggest that the structure of VDR is altered in a vitamin D analog-specific way, resulting in selective interactions of VDR with coactivators. Such selective interaction of coactivators with VDR may specify the array of biological actions of a vitamin D analog like OCT, possibly through activating a particular set of target gene promoters.

* Corresponding author. Mailing address: Institute of Molecular and Cellular Biosciences, The University of Tokyo, Yayoi 1-1-1, Bunkyo-ku, Tokyo 113, Japan. Phone: 81-3-5802-8632. Fax: 81-3-5684-8342. E-mail: uskato{at}hongo.ecc.u-tokyo.ac.jp.

Molecular and Cellular Biology, February 1999, p. 1049-1055, Vol. 19, No. 2
0270-7306/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:

  • Valdivielso, J. M., Cannata-Andia, J., Coll, B., Fernandez, E. (2009). A new role for vitamin D receptor activation in chronic kidney disease. Am. J. Physiol. Renal Physiol. 297: F1502-F1509 [Abstract] [Full Text]  
  • EELEN, G., VERLINDEN, L., LAUREYS, J., MARCELIS, S., DE CLERCQ, P., MATHIEU, C., BOUILLON, R., VERSTUYF, A. (2009). Antiproliferative and Calcemic Actions of Trans-Decalin CD-Ring Analogs of 1,25-Dihydroxyvitamin D3. Anticancer Res 29: 3579-3584 [Abstract] [Full Text]  
  • Zella, L. A., Meyer, M. B., Nerenz, R. D., Pike, J. W. (2009). The Enhanced Hypercalcemic Response to 20-Epi-1,25-Dihydroxyvitamin D3 Results from a Selective and Prolonged Induction of Intestinal Calcium-Regulating Genes. Endocrinology 150: 3448-3456 [Abstract] [Full Text]  
  • Castillo, A. I., Sanchez-Martinez, R., Jimenez-Lara, A. M., Steinmeyer, A., Zugel, U., Aranda, A. (2006). Characterization of Vitamin D Receptor Ligands with Cell-Specific and Dissociated Activity. Mol. Endocrinol. 20: 3093-3104 [Abstract] [Full Text]  
  • Ogawa, S., Oishi, H., Mezaki, Y., Kouzu-Fujita, M., Matsuyama, R., Nakagomi, M., Mori, E., Murayama, E., Nagasawa, H., Kitagawa, H., Yanagisawa, J., Yano, T., Kato, S. (2005). Repressive domain of unliganded human estrogen receptor {alpha} associates with Hsc70. GENES CELLS 10: 1095-1102 [Abstract] [Full Text]  
  • Furutani, T., Takeyama, K.-i., Tanabe, M., Koutoku, H., Ito, S., Taniguchi, N., Suzuki, E., Kudoh, M., Shibasaki, M., Shikama, H., Kato, S. (2005). Human Expanded Polyglutamine Androgen Receptor Mutants in Neurodegeneration as a Novel Ligand Target. J. Pharmacol. Exp. Ther. 315: 545-552 [Abstract] [Full Text]  
  • Eelen, G., Verlinden, L., Rochel, N., Claessens, F., De Clercq, P., Vandewalle, M., Tocchini-Valentini, G., Moras, D., Bouillon, R., Verstuyf, A. (2005). Superagonistic Action of 14-epi-Analogs of 1,25-Dihydroxyvitamin D Explained by Vitamin D Receptor-Coactivator Interaction. Mol. Pharmacol. 67: 1566-1573 [Abstract] [Full Text]  
  • Meijer, O. C., Kalkhoven, E., van der Laan, S., Steenbergen, P. J., Houtman, S. H., Dijkmans, T. F., Pearce, D., de Kloet, E. R. (2005). Steroid Receptor Coactivator-1 Splice Variants Differentially Affect Corticosteroid Receptor Signaling. Endocrinology 146: 1438-1448 [Abstract] [Full Text]  
  • Adachi, R., Honma, Y., Masuno, H., Kawana, K., Shimomura, I., Yamada, S., Makishima, M. (2005). Selective activation of vitamin D receptor by lithocholic acid acetate, a bile acid derivative. J. Lipid Res. 46: 46-57 [Abstract] [Full Text]  
  • Aihara, K.-i., Azuma, H., Akaike, M., Ikeda, Y., Yamashita, M., Sudo, T., Hayashi, H., Yamada, Y., Endoh, F., Fujimura, M., Yoshida, T., Yamaguchi, H., Hashizume, S., Kato, M., Yoshimura, K., Yamamoto, Y., Kato, S., Matsumoto, T. (2004). Disruption of Nuclear Vitamin D Receptor Gene Causes Enhanced Thrombogenicity in Mice. J. Biol. Chem. 279: 35798-35802 [Abstract] [Full Text]  
  • Peng, L., Malloy, P. J., Feldman, D. (2004). Identification of a Functional Vitamin D Response Element in the Human Insulin-Like Growth Factor Binding Protein-3 Promoter. Mol. Endocrinol. 18: 1109-1119 [Abstract] [Full Text]  
  • Ismail, A., Nguyen, C. V., Ahene, A., Fleet, J. C., Uskokovic, M. R., Peleg, S. (2004). Effect of Cellular Environment on the Selective Activation of the Vitamin D Receptor by 1{alpha},25-Dihydroxyvitamin D3 and Its Analog 1{alpha}-Fluoro-16-Ene-20-Epi-23-Ene-26,27-Bishomo-25-Hydroxyvitamin D3 (Ro-26-9228). Mol. Endocrinol. 18: 874-887 [Abstract] [Full Text]  
  • Adachi, R., Shulman, A. I., Yamamoto, K., Shimomura, I., Yamada, S., Mangelsdorf, D. J., Makishima, M. (2004). Structural Determinants for Vitamin D Receptor Response to Endocrine and Xenobiotic Signals. Mol. Endocrinol. 18: 43-52 [Abstract] [Full Text]  
  • Bettoun, D. J., Burris, T. P., Houck, K. A., Buck, D. W. II, Stayrook, K. R., Khalifa, B., Lu, J., Chin, W. W., Nagpal, S. (2003). Retinoid X Receptor Is a Nonsilent Major Contributor to Vitamin D Receptor-Mediated Transcriptional Activation. Mol. Endocrinol. 17: 2320-2328 [Abstract] [Full Text]  
  • Albert, S., Gaudan, S., Knigge, H., Raetsch, A., Delgado, A., Huhse, B., Kirsch, H., Albers, M., Rebholz-Schuhmann, D., Koegl, M. (2003). Computer-Assisted Generation of a Protein-Interaction Database for Nuclear Receptors. Mol. Endocrinol. 17: 1555-1567 [Abstract] [Full Text]  
  • Wu, Y., Chin, W. W., Wang, Y., Burris, T. P. (2003). Ligand and Coactivator Identity Determines the Requirement of the Charge Clamp for Coactivation of the Peroxisome Proliferator-activated Receptor gamma. J. Biol. Chem. 278: 8637-8644 [Abstract] [Full Text]  
  • Kamao, M., Tatematsu, S., Hatakeyama, S., Ozono, K., Kubodera, N., Reddy, G. S., Okano, T. (2003). Two Novel Metabolic Pathways of 22-Oxacalcitriol (OCT). C-25 DEHYDRATION AND C-3 EPIMERIZATION AND BIOLOGICAL ACTIVITIES OF NOVEL OCT METABOLITES. J. Biol. Chem. 278: 1463-1471 [Abstract] [Full Text]  
  • McKenna, N. J., O'Malley, B. W. (2002). Minireview: Nuclear Receptor Coactivators--An Update. Endocrinology 143: 2461-2465 [Abstract] [Full Text]  
  • Kitagawa, H., Yanagisawa, J., Fuse, H., Ogawa, S., Yogiashi, Y., Okuno, A., Nagasawa, H., Nakajima, T., Matsumoto, T., Kato, S. (2002). Ligand-Selective Potentiation of Rat Mineralocorticoid Receptor Activation Function 1 by a CBP-Containing Histone Acetyltransferase Complex. Mol. Cell. Biol. 22: 3698-3706 [Abstract] [Full Text]  
  • Peleg, S., Uskokovic, M., Ahene, A., Vickery, B., Avnur, Z. (2002). Cellular and Molecular Events Associated with the Bone-Protecting Activity of the Noncalcemic Vitamin D Analog Ro-26-9228 in Osteopenic Rats. Endocrinology 143: 1625-1636 [Abstract] [Full Text]  
  • Yagishita, N., Yamamoto, Y., Yoshizawa, T., Sekine, K., Uematsu, Y., Murayama, H., Nagai, Y., Krezel, W., Chambon, P., Matsumoto, T., Kato, S. (2001). Aberrant Growth Plate Development in VDR/RXR{gamma} Double Null Mutant Mice. Endocrinology 142: 5332-5341 [Abstract] [Full Text]  
  • Cesario, R. M., Klausing, K., Razzaghi, H., Crombie, D., Rungta, D., Heyman, R. A., Lala, D. S. (2001). The Rexinoid LG100754 Is a Novel RXR:PPAR{gamma} Agonist and Decreases Glucose Levels in Vivo. Mol. Endocrinol. 15: 1360-1369 [Abstract] [Full Text]  
  • FINCH, J. L., DUSSO, A. S., PAVLOPOULOS, T., SLATOPOLSKY, E. A. (2001). Relative Potencies of 1,25-(OH)2D3 and 19-Nor-1,25-(OH)2D2 on Inducing Differentiation and Markers of Bone Formation in MG-63 Cells. J. Am. Soc. Nephrol. 12: 1468-1474 [Abstract] [Full Text]  
  • Bramlett, K. S., Wu, Y., Burris, T. P. (2001). Ligands Specify Coactivator Nuclear Receptor (NR) Box Affinity for Estrogen Receptor Subtypes. Mol. Endocrinol. 15: 909-922 [Abstract] [Full Text]  
  • BROWN, A. J., FINCH, J., TAKAHASHI, F., SLATOPOLSKY, E. (2000). Calcemic Activity of 19-Nor-1,25(OH)2D2 Decreases with Duration of Treatment. J. Am. Soc. Nephrol. 11: 2088-2094 [Abstract] [Full Text]  
  • HOLLIDAY, L. S., GLUCK, S. L., SLATOPOLSKY, E., BROWN, A. J. (2000). 1,25-Dihydroxy-19-nor-vitamin D2, a Vitamin D Analog with Reduced Bone Resorbing Activity In Vitro. J. Am. Soc. Nephrol. 11: 1857-1864 [Abstract] [Full Text]  
  • Fuse, H., Kitagawa, H., Kato, S. (2000). Characterization of Transactivational Property and Coactivator Mediation of Rat Mineralocorticoid Receptor Activation Function-1 (AF-1). Mol. Endocrinol. 14: 889-899 [Abstract] [Full Text]  
  • Herdick, M., Bury, Y., Quack, M., Uskokovic, M. R., Polly, P., Carlberg, C. (2000). Response Element and Coactivator-Mediated Conformational Change of the Vitamin D3 Receptor Permits Sensitive Interaction with Agonists. Mol. Pharmacol. 57: 1206-1217 [Abstract] [Full Text]  
  • Northrop, J. P., Nguyen, D., Piplani, S., Olivan, S. E., Kwan, S. T-S., Go, N. F., Hart, C. P., Schatz, P. J. (2000). Selection of Estrogen Receptor {beta}- and Thyroid Hormone Receptor {beta}-Specific Coactivator-Mimetic Peptides Using Recombinant Peptide Libraries. Mol. Endocrinol. 14: 605-622 [Abstract] [Full Text]  
  • Verlinden, L., Verstuyf, A., Van Camp, M., Marcelis, S., Sabbe, K., Zhao, X.-Y., Pierre De Clercq, , Vandewalle, M., Bouillon, R. (2000). Two Novel 14-Epi-Analogues of 1,25-Dihydroxyvitamin D3 Inhibit the Growth of Human Breast Cancer Cells in Vitro and in Vivo. Cancer Res. 60: 2673-2679 [Abstract] [Full Text]  
  • Leo, C., Li, H., Chen, J. D. (2000). Differential Mechanisms of Nuclear Receptor Regulation by Receptor-associated Coactivator 3. J. Biol. Chem. 275: 5976-5982 [Abstract] [Full Text]  
  • Thénot, S., Bonnet, S., Boulahtouf, A., Margeat, E., Royer, C. A., Borgna, J.-L., Cavaillès, V. (1999). Effect of Ligand and DNA Binding on the Interaction between Human Transcription Intermediary Factor 1{alpha} and Estrogen Receptors. Mol. Endocrinol. 13: 2137-2150 [Abstract] [Full Text]  
  • Ozono, K., Saito, M., Miura, D., Michigami, T., Nakajima, S., Ishizuka, S. (1999). Analysis of the Molecular Mechanism for the Antagonistic Action of a Novel 1alpha ,25-Dihydroxyvitamin D3 Analogue toward Vitamin D Receptor Function. J. Biol. Chem. 274: 32376-32381 [Abstract] [Full Text]  
  • Endoh, H., Maruyama, K., Masuhiro, Y., Kobayashi, Y., Goto, M., Tai, H., Yanagisawa, J., Metzger, D., Hashimoto, S., Kato, S. (1999). Purification and Identification of p68 RNA Helicase Acting as a Transcriptional Coactivator Specific for the Activation Function 1 of Human Estrogen Receptor alpha. Mol. Cell. Biol. 19: 5363-5372 [Abstract] [Full Text]  
  • Yang, W., Freedman, L. P. (1999). 20-Epi Analogues of 1,25-Dihydroxyvitamin D3 Are Highly Potent Inducers of DRIP Coactivator Complex Binding to the Vitamin D3 Receptor. J. Biol. Chem. 274: 16838-16845 [Abstract] [Full Text]  
  • Kodera, Y., Takeyama, K.-i., Murayama, A., Suzawa, M., Masuhiro, Y., Kato, S. (2000). Ligand type-specific Interactions of Peroxisome Proliferator-activated Receptor gamma with Transcriptional Coactivators. J. Biol. Chem. 275: 33201-33204 [Abstract] [Full Text]  
  • Kobayashi, Y., Kitamoto, T., Masuhiro, Y., Watanabe, M., Kase, T., Metzger, D., Yanagisawa, J., Kato, S. (2000). p300 Mediates Functional Synergism between AF-1 and AF-2 of Estrogen Receptor alpha and beta by Interacting Directly with the N-terminal A/B Domains. J. Biol. Chem. 275: 15645-15651 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»